Company: THC
Filing Date: 2025-02-18
Form Type: 10-K
Source: 0000070318-25-000009
Chunk: 138

Company: TENET HEALTHCARE CORP
Filing Date: 2025-02-18
Form: 10-K
Item: Item 8
Chunk 138
---
 of the subject shares.Pursuant to the terms of our stock‑based compensation plans, awards granted under the plan vest and may be exercised as determined by the human resources committee of our board of directors. In the event of a change in control, the human resources committee of our board of directors may, at its sole discretion without obtaining shareholder approval, accelerate the vesting or performance periods of the awards.At December 31, 2024, assuming outstanding performance‑based RSUs for which performance has not yet been determined will achieve target performance, approximately 8,419 thousand shares of common stock were available under our 2019 Stock Incentive Plan for future stock option grants and other equity incentive awards, including RSUs. The accompanying Consolidated Statements of Operations include pre-tax compensation costs related to our stock‑based compensation arrangements of $67 million, $66 million and $56 million for the years ended December 31, 2024, 2023 and 2022, respectively. At December 31, 2024, there were $57 million of total unrecognized compensation costs related to our share-based compensation awards. These costs are expected to be recognized over a weighted average (“Wtd. Avg.”) period of 1.8 years.Stock OptionsThe following table presents information about our stock option activity during the years ended December 31, 2024, 2023 and 2022: Number of OptionsWtd. Avg.Exercise PricePer ShareAggregateIntrinsic ValueWtd. Avg.RemainingContractual Life   (In Millions) Outstanding at December 31, 2021520,998 $23.90   Exercised(60,051)$28.26   Outstanding at December 31, 2022460,947 $23.33   Exercised(76,507)$26.07   Outstanding at December 31, 2023384,440 $22.79   Exercised(197,943)$21.86   Outstanding at December 31, 2024186,497 $23.76 $19 3.4 years

97

Table of Contents

The stock options exercised during the year ended December 31, 2024 had an aggregate intrinsic value of $19 million, and the stock options exercised during both of the years ended December 31, 2023 and 2022 had aggregate intrinsic